Dublin, Feb. 26, 2018 -- The "Biochips and Microarrays - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine
The report provides current share of each segment: market size in 2017 and projected value for the years 2022 and 2027. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics.
The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.
Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. Biochip and Microarray Technologies
3. Microfluidics-based Biochips and Microarrays
4. Protein Biochips
5. Nanobiotechnology-based Biochips & Microarrays
6. Biochips & Microarrays for Epigenetics
7. Applications of Microarrays in Drug Discovery & Development
8. Biochips for Biomarkers, Molecular Diagnostics & Personalized
9. Markets
10. Companies
11. References
For more information about this report visit https://www.researchandmarkets.com/research/43ljxm/_biochips_and?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology


Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
OpenAI Restricts Astra AI Over Cyberattack Risks 



